Tay JR, Cortés-Algara AL, Rodríguez-Bandala C, Núñez-Hernández LF, Cortés-Vásquez A

Language: Spanish
References: 21
Page: 5-9
PDF size: 614.49 Kb.

ABSTRACT

Introduction: adenomyosis and uterine fibroids are estrogen-dependent conditions that may coexist and modify clinical presentation and surgical outcomes when occurring simultaneously. Objective: to compare the clinical and surgical characteristics of patients undergoing minimally invasive hysterectomy diagnosed with adenomyosis, uterine fibroids, or both conditions. Material and methods: an observational, cross-sectional, and retrospective study was conducted at the Gynecology and Obstetrics Hospital of the Instituto Materno Infantil del Estado de México. Seventy-five patients who underwent minimally invasive hysterectomy between January 2024 and July 2025 were included. Clinical, gynecologic-obstetric variables and surgical parameters were analyzed and compared with histopathological findings. Results: age was higher in the combined-diagnosis group (p < 0.05). Ultrasound diagnosed uterine fibroids in 85.3%, adenomyosis in 1.3%, and both conditions in 5.3% of cases. Operative time (p = 0.001) and intraoperative blood loss (p = 0.004) were lower in robot-assisted hysterectomy. In conventional laparoscopy, the combined group showed shorter operative time (p = 0.02), while the adenomyosis group had lower intraoperative blood loss (p = 0.01). Conclusions: the combined diagnosis was associated with older age, without significant differences in other clinical parameters; however, variations in surgical indicators were observed according to the surgical approach.

REFERENCES

1. Vannuccini S, Jain V, Critchley H, Petraglia F. From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health. Fertil Steril. 2022; 118 (4): 625-636.

2. Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018; 24 (1): 59-85.

3. Stewart EA, Nicholson WK, Bradley L, Borah BJ. The Burden of Uterine Fibroids for African-American Women: Results of a National Survey. J Womens Health. 2013; 22 (10): 807-816.

4. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22 (6): 665-686.

5. Vannuccini S, Clemenza S, Rossi M, Petraglia F. Hormonal treatments for endometriosis: the endocrine background. Rev Endocr Metab Disord. 2022; 23 (3): 333-355.

6. Leppert PC, Jayes FL, Segars JH. The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstet Gynecol Int. 2014; 2014: 1-12.

7. Levgur M. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol. 2000; 95 (5): 688-691.

8. Mishra I, Melo P, Easter C, Sephton V, Dhillon-Smith R, Coomarasamy A. Prevalence of adenomyosis in women with subfertility: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2023; 62 (1): 23-41.

9. Upson K, Missmer SA. Epidemiology of adenomyosis. Semin Reprod Med. 2020; 38 (02/03): 89-107.

10. Kashani BN, Centini G, Morelli SS, Weiss G, Petraglia F. Role of medical management for uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 85-103.

11. Goksever-Celik H, Erkan IBO, Topcu EG, Sozen I, Gunduz N, Saricoban CT et al. Adenomyosis and coexisting gynecologic pathologies: how often do they coexist? Int J Gynecol Obstet. 2025; 171 (2): 728-735.

12. Güzel AI, Akselim B, Erkilinc S, Kokanali K, Tokmak A, Dolmus B et al. Risk factors for adenomyosis, leiomyoma and concurrent adenomyosis and leiomyoma. J Obstet Gynaecol Res. 2015; 41 (6): 932-937.

13. Brucker SY, Huebner M, Wallwiener M, Stewart EA, Ebersoll S, Schoenfisch B et al. Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study. Fertil Steril. 2014; 101 (1): 237-241.e1. doi: 10.1016/j.fertnstert.2013.09.038.

14. Ates S, Ozcan P, Aydin S, Karaca N. Differences in clinical characteristics for the determination of adenomyosis coexisting with leiomyomas. J Obstet Gynaecol Res. 2016; 42 (3): 307-312.

15. Ochoa-Castro MA. Utilidad de la ecografía transvaginal frente a estudios anatomopatológicos en pacientes con miomatosis uterina del Hospital José Carrasco Arteaga. Cuenca. Ecuador. 2009. [Cuenca]: Universidad De Cuenca Facultad De Ciencias Médicas Postgrado En Imagenologí a; 2009.

16. Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018; 143 (3): 393-408.

17. González G. Sub diagnóstico de adenomiosis en el Hospital de la Mujer. México: Universidad Nacional Autónoma de México; 2010.

18. Botsis D, Kassanos D, Antoniou G, Pyrgiotis E, Karakitsos P, Kalogirou D. Adenomyoma and leiomyoma: Differential diagnosis with transvaginal sonography. J Clin Ultrasound. 1998; 26 (1): 21-25.

19. Santulli P, Vannuccini S, Bourdon M, Chapron C, Petraglia F. Adenomyosis: the missed disease. Reprod Biomed Online. 2025; 50 (4): 104837.

20. Billfeldt NK, Borgfeldt C, Lindkvist H, Stjerndahl JH, Ankardal M. A Swedish population-based evaluation of benign hysterectomy, comparing minimally invasive and abdominal surgery. Eur J Obstetr Gynecol Reprod Biol. 2018; 222: 113-118.

21. Vargas SR, Prado NS, Basilio FP, Garrido BJ, Castillo DR, Clavero PM et al. Histerectomía total laparoscópica asistida por robot: experiencia de Clínica Indisa. Rev Chil Obstet Ginecol. 2013; 78 (4): 304-309.